tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

HALO Stock Latest News

Halozyme price target raised to $60 from $50 at Benchmark
The FlyHalozyme price target raised to $60 from $50 at Benchmark
1M ago
HALO
Halozyme: Roche’s OCREVUS SC with ENHANZE receives EC approval
PremiumThe Fly
Halozyme: Roche’s OCREVUS SC with ENHANZE receives EC approval
1M ago
HALO
Halozyme participates in a conference call with JPMorgan
PremiumThe Fly
Halozyme participates in a conference call with JPMorgan
2M ago
HALO
Lyft, 3M upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Lyft, 3M upgraded: Wall Street’s top analyst calls
2M ago
CC
AER
Halozyme price target raised to $58 from $48 at Wells Fargo
PremiumThe Fly
Halozyme price target raised to $58 from $48 at Wells Fargo
2M ago
HALO
Halozyme price target raised to $65 from $50 at H.C. Wainwright
PremiumThe FlyHalozyme price target raised to $65 from $50 at H.C. Wainwright
2M ago
HALO
Halozyme downgraded to Neutral after rally at Piper Sandler
PremiumThe Fly
Halozyme downgraded to Neutral after rally at Piper Sandler
2M ago
HALO
Halozyme downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Halozyme downgraded to Neutral from Overweight at Piper Sandler
2M ago
HALO
Halozyme price target raised to $44 from $41 at Goldman Sachs
PremiumThe Fly
Halozyme price target raised to $44 from $41 at Goldman Sachs
2M ago
HALO
Halozyme Raises Full Year 2024 Financial Guidance and Updates 5-Year Financial Outlook
PremiumPress Releases
Halozyme Raises Full Year 2024 Financial Guidance and Updates 5-Year Financial Outlook
2M ago
HALO
Halozyme raises FY24 non-GAAP EPS view to $3.65-$4.05 from $3.55-$3.90
PremiumThe Fly
Halozyme raises FY24 non-GAAP EPS view to $3.65-$4.05 from $3.55-$3.90
2M ago
HALO
Halozyme granted European patent covering ENHANZE drug delivery platform
PremiumThe Fly
Halozyme granted European patent covering ENHANZE drug delivery platform
2M ago
HALO
Halozyme and Bristol Myers’ combination receives updated FDA action date
PremiumThe FlyHalozyme and Bristol Myers’ combination receives updated FDA action date
2M ago
BMY
HALO
Halozyme price target raised to $45 from $39 at Leerink
PremiumThe Fly
Halozyme price target raised to $45 from $39 at Leerink
3M ago
HALO
Halozyme price target lowered to $71 from $72 at JMP Securities
PremiumThe Fly
Halozyme price target lowered to $71 from $72 at JMP Securities
3M ago
HALO
Halozyme sees FY24 revenue $620M-$630M, consensus $614.12M
PremiumThe Fly
Halozyme sees FY24 revenue $620M-$630M, consensus $614.12M
3M ago
HALO
Halozyme sees Q2 EPS (11c)-5c, consensus 0c
PremiumThe Fly
Halozyme sees Q2 EPS (11c)-5c, consensus 0c
3M ago
HALO
Halozyme sees FY24 adjusted EPS $3.55-$3.90, consensus $3.68
PremiumThe Fly
Halozyme sees FY24 adjusted EPS $3.55-$3.90, consensus $3.68
3M ago
HALO
Halozyme reports Q1 non-GAAP EPS 79c, consensus 69c
PremiumThe Fly
Halozyme reports Q1 non-GAAP EPS 79c, consensus 69c
3M ago
HALO
Halozyme Therapeutics (HALO) Q1 Earnings Cheat Sheet
PremiumPre-EarningsHalozyme Therapeutics (HALO) Q1 Earnings Cheat Sheet
3M ago
HALO
Halozyme initiated with an Outperform at TD Cowen
PremiumThe Fly
Halozyme initiated with an Outperform at TD Cowen
5M ago
HALO
Halozyme price target raised to $50 from $48 at H.C. Wainwright
PremiumThe Fly
Halozyme price target raised to $50 from $48 at H.C. Wainwright
5M ago
HALO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >